Progranulin plasma levels as potential biomarker for the identification of GRN deletion carriers. A case with atypical onset as clinical amnestic Mild Cognitive Impairment converted to Alzheimer's disease

Journal of the Neurological Sciences

Volumn 287, Issue 1-2, 2009, Pages 291-293

  Carecchio, Miryam ^a,b   Fenoglio, Chiara ^a   De Riz, Milena ^a   Guidi, Ilaria ^c   Comi, Cristoforo ^b,d   Cortini, Francesca ^a   Venturelli, Eliana ^a   Restelli, Ilaria ^a   Cantoni, Claudia ^a   Bresolin, Nereo ^a   Monaco, Francesco ^b   Scarpini, Elio ^a   Galimberti, Daniela ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^c RHO HOSPITAL   (Italy)

^d Neurorehabilitation Institute ML Novarese   (Italy)

Author keywords

Alzheimer's disease; Clinical phenotype; Frontotemporal Lobar Degeneration; Mild Cognitive Impairment; Mutation; Progranulin

Indexed keywords

CITALOPRAM; DONEPEZIL; LEVODOPA; PROGRANULIN; RAMIPRIL; RIVASTIGMINE;

AGED; ALZHEIMER DISEASE; ANXIETY DISORDER; APRAXIA; ARTICLE; BEHAVIOR DISORDER; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FRONTOTEMPORAL DEMENTIA; GENE DELETION; HETEROZYGOTE DETECTION; HUMAN; HYPERTENSION; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TEST; PARKINSONISM; PRIORITY JOURNAL;

AGED; ALZHEIMER DISEASE; BIOLOGICAL MARKERS; BRAIN; BRAIN CHEMISTRY; COGNITION DISORDERS; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; FEMALE; GAIT DISORDERS, NEUROLOGIC; GENE DELETION; GENETIC MARKERS; HETEROZYGOTE DETECTION; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MENTAL DISORDERS; PARKINSON DISEASE; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY;

EID: 70350618915     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2009.07.011     Document Type: Article

References (17)

1. Baker M., Mackenzie I.R., Pickering-Brown S.M., Gass J., Rademakers R., Lindholm C., et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 442 7105 (2006) 916-919
2. Cruts M., Gijselinck I., van der Zee J., Engelborghs S., Wils H., Pirici D., et al. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature 442 7105 (2006) 920-924
3. van Swieten J.C., and Heutink P. Mutations in progranulin (GRN) within the spectrum of clinical and pathological phenotypes of frontotemporal dementia. Lancet Neurol 7 10 (2008) 965-974
4. Ghidoni R., Benussi L., Glionna M., Franzoni M., and Binetti G. Low plasma progranulin levels predict progranulin mutations in Frontotemporal Lobar Degeneration. Neurology 71 16 (2008) 1235-1239
5. Finch N., Baker M., Crook R., Swanson K., Kuntz K., Surtees R., et al. Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members. Brain 132 Pt 3 (2009) 583-591
6. Sleegers K., Brouwers N., Van Damme P., Engelborghs S., Gijselinck I., van der Zee J., et al. Serum biomarker for progranulin-associated Frontotemporal Lobar Degeneration. Ann Neurol 65 5 (2009) 603-609
7. Petersen R.C., Smith G.E., Waring S.C., Ivnik R.J., Tangalos E.G., and Kokmen E. Mild Cognitive Impairment: clinical characterization and outcome. Arch Neurol 56 3 (1999) 303-308
8. McKhann G., Drachman D.A., Folstein M., Katzman R., Price D.L., and Stadlan E.M. Clinical diagnosis of Alzheimer's disease - report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34 (1984) 939-944
9. Benussi L., Ghidoni R., Pegoiani E., Moretti D.V., Zanetti O., and Binetti G. Progranulin Leu271LeufsX10 is one of the most common FTLD and CBS associated mutations worldwide. Neurobiol Dis 33 3 (2009) 379-385
10. Le Ber I., Camuzat A., Hannequin D., Pasquier F., Guedj E., Rovelet-Lecrux A., et al. Phenotype variability in progranulin mutation carriers: a clinical, neuropsychological, imaging and genetic study. Brain 131 Pt 3 (2008) 732-746
11. Brouwers N., Nuytemans K., van der Zee J., Gijselinck I., Engelborghs S., Theuns J., et al. Alzheimer and Parkinson diagnoses in progranulin null mutation carriers in an extended founder family. Arch Neurol 64 10 (2007) 1436-1446
12. Rovelet-Lecrux A., Deramecourt V., Legallic S., Maurage C.A., Le Ber I., Brice A., et al. Deletion of the progranulin gene in patients with Frontotemporal Lobar Degeneration or Parkinson disease. Neurobiol Dis 31 1 (2008) 41-45
13. Benussi L., Binetti G., Sina E., Gigola L., Bettecken T., Meitinger T., and Ghidoni R. A novel deletion in progranulin gene is associated with FTDP-17 and CBS. Neurobiol Aging 29 3 (2008) 427-435
14. Josephs K.A., Ahmed Z., Katsuse O., Parisi J.F., Boeve B.F., Knopman D.S., et al. Neuropathologic features of Frontotemporal Lobar Degeneration with ubiquitin-positive inclusions with progranulin gene (PGRN) mutations. J Neuropathol Exp Neurol 66 2 (2007) 142-151
15. Whitwell J.L., Jack Jr. C.R., Baker M., Rademakers R., Adamson J., Boeve B.F., et al. Voxel-based morphometry in Frontotemporal Lobar Degeneration with ubiquitin-positive inclusions with and without progranulin mutations. Arch Neurol 64 3 (2007) 371-376
16. Boeve B.F., Baker M., Dickson D.W., Parisi J.E., Giannini C., Josephs K.A., et al. Frontotemporal dementia and parkinsonism associated with the IVS1+1G>A mutation in progranulin: a clinicopathologic study. Brain 129 (2006) 3103-3114
17. Kelley B.J., Haidar W., Boeve B.F., Baker M., Graff-Radford N.R., Krefft T., et al. Prominent phenotypic variability associated with mutations in Progranulin. Neurobiol Aging 30 5 (2009) 739-751